TG Therapeutics | Attività Correnti



Current Assets Cambiamento Data
AbbVie USD 27.68B 2.09B 2025-03
Alaunos Therapeutics USD 2.76M 795K 2024-12
Amgen USD 26.73B 195M 2025-06
Ardelyx USD 351.57M 4.88M 2025-06
Arrowhead Research USD 946.92M 188.3M 2025-06
Bayer EUR 33.75B 1.08B 2025-06
Biogen USD 7.97B 341.7M 2025-06
Corcept Therapeutics USD 443.11M 4.61M 2025-06
Dynavax Technologies USD 785.71M 30.26M 2025-06
Gilead Sciences USD 14.72B 2.18B 2025-06
J&J USD 71.55B 15.66B 2025-03
Novartis USD 25.94B 831M 2025-06
PTC Therapeutics USD 2.27B 43.53M 2025-06
Regeneron Pharmaceuticals USD 16.86B 712.2M 2025-06
Roche Holding CHF 40.04B 6.41B 2024-12
TG Therapeutics USD 663.96M 19.45M 2025-06
Vertex Pharmaceuticals USD 10.43B 419.1M 2025-06


TG Therapeutics Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Sep 2025.